TLR4 and metabolic dysfunction-associated steatotic liver disease: Subsequent hepatic Toll-like receptor 4 (TLR4) activation by translocated LPS stimulates immune cells, induces pro-inflammatory cytokine production, and drives progression from steatosis to fibrosis, accelerating NAFLD pathogenesis [54–56].